StemCell Therapy

What Are Stem Cells and Stem Cell Therapy Stemenhance
http://www.stemcellproduct.net This video gives you the definition, facts, and understanding on what are stem cells, that there are two of them embryonic and adult stem cells, how they work and the uses of stem cell when the tissue is affected in your body and how messengers signal the bone marrow to release adult stem cells to help in the repair of the injured tissue. Why this information is exciting for me to do a video is because I see stemcells as the best way of how to produce optimal health in your body. The way I look at it is that optimal health equals the number of healthy cells in your body and the only way the body repairs a damaged area is by creating and sending adult stem cells to that area. That #39;s why I #39;m introducing a stem cell product from a nutrition company who patented a stem cell enhancer which supports the release of adult stem cells. What will also excite you too is that Stemtech (the stemcell company) has also come out with two other products that will also optimize the circulation of these stem cells and other nutrients and aid in the ability for them to move and migrate into the affected tissue where they can transform and duplicate into fresh, healthy new cell tissue. So in my eyes having products like these will help anyone in my pursuit of health and wellness. I know it #39;s helping me strengthening my cells in my body after being diagnosed with chronic fatigue syndrome 20 plus years ago because I know how important nutrition and cell help to gain my ...From:Jennifer MarksViews:1 0ratingsTime:06:37More inHowto Style

Read more here:
What Are Stem Cells and Stem Cell Therapy Stemenhance - Video

In the womb, a ball of identical cells gives rise to varied cell types that ultimately form highly ordered structures and then the full panoply of organs in the human body. The process advances according to an internal biological script that directs each fold and crease of tissue to assume exactly the proper shape and dimension.

[More]

Source:
http://rss.sciam.com/click.phdo?i=1e6abdd024c3b29c15070219c99ad16a

The California stem cell agency said
today it does not plan to reactivate the $25 million loan to assist
in Geron's spinal injury clinical trial despite an impending deal that would turn the effort over to BioTime, Inc.

“That (earlier) loan was specific to
Geron and when the trial was ended the loan ended too. Of course if
Biotime and Geron do complete their deal then Biotime would be free
to apply to us for a new disease team grant.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/DS-6n2DoRy0/biotime-will-have-to-compete-for.html

Geron Corp., which once pioneered human
embryonic stem cell research, is close to selling off its hESC business in a complicated deal involving two former CEOs of the company and
BioTime, Inc., of Alameda, Ca.

“ BioTime would contribute
to BAC $5 million in cash, $30 million of BioTime common
shares, warrants to purchase eight (8) million common shares
of BioTime at a pre-specified price, rights to use certain
human embryonic stem cell lines, and minority stakes in two of
BioTime’s subsidiaries. In addition, a private investor would
invest $5 million in cash in BAC. 

“Following consummation of the
potential transaction, Geron stockholders would receive
shares representing 21.4% of the common stock of BAC as well as
warrants to purchase 8 million shares of BioTime common
stock at a pre-specified price. BioTime would own
approximately 71.6%, and a private investor would own approximately
7.0% of the outstanding BAC common stock for their $5
million investment. BioTime would also receive
warrants that would enable it to increase its ownership in BAC by
approximately 2%, which would reduce the Geron stockholders’
ownership in BAC to 19.2%. BAC would also be committed to pay
to Geron royalties on the sale of products that are
commercialized in reliance upon Geron patents acquired by
BAC.”

“The offer couldn’t come at a
better time for Geron, which in recent months has started to feel
pressure from its shareholders to boost its stock price and move
products through the pipeline. Since last November, when the company
announced its decision to shutter its hESC and regenerative medicine
business and funnel its resources into developing telomerase-related
treatments for cancer, the stock price has dropped more than 50
percent to $1.30 a share. Geron claimed the move was simply to save
money, but many took the decision—which effectively terminated a
clinical trial of an hESC treatment for spinal cord injury—as a
setback for the entire field." 

News coverage of yesterday's
announcement was light. Here is a link to a piece by Ryan McBride on
Fierce Biotech.

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/b-E7JaABIOI/geron-biotime-deal-moves-forward-with.html

Yoshiki Sasai is not just an ordinary tissue engineer who tries to coax stem cells to grow into fully formed bodily structures. It is true that Sasai has made his mark by taking on big projects like using stem cells to whip up a retina, cortical tissue and the cerebellum, involved with balance and movement. But his research has gone deeper by delving into the way stem cells organize themselves into complex structures under the influence of genes and the prenatal environment. Read a profile of Sasai here to accompany “ Grow Your Own Eye ,” Sasai’s own account of growing a retina in the November Scientific American .

[More]

Source:
http://rss.sciam.com/click.phdo?i=7291cadd43ac0cf30e9687431d559702

In the womb, a ball of identical cells gives rise to varied cell types that ultimately form highly ordered structures and then the full panoply of organs in the human body. The process advances according to an internal biological script that directs each fold and crease of tissue to assume exactly the proper shape and dimension.

[More]

Source:
http://rss.sciam.com/click.phdo?i=1e6abdd024c3b29c15070219c99ad16a

The California stem cell agency said
today it does not plan to reactivate the $25 million loan to assist
in Geron's spinal injury clinical trial despite an impending deal that would turn the effort over to BioTime, Inc.

“That (earlier) loan was specific to
Geron and when the trial was ended the loan ended too. Of course if
Biotime and Geron do complete their deal then Biotime would be free
to apply to us for a new disease team grant.”

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/DS-6n2DoRy0/biotime-will-have-to-compete-for.html

Geron Corp., which once pioneered human
embryonic stem cell research, is close to selling off its hESC business in a complicated deal involving two former CEOs of the company and
BioTime, Inc., of Alameda, Ca.

“ BioTime would contribute
to BAC $5 million in cash, $30 million of BioTime common
shares, warrants to purchase eight (8) million common shares
of BioTime at a pre-specified price, rights to use certain
human embryonic stem cell lines, and minority stakes in two of
BioTime’s subsidiaries. In addition, a private investor would
invest $5 million in cash in BAC. 

“Following consummation of the
potential transaction, Geron stockholders would receive
shares representing 21.4% of the common stock of BAC as well as
warrants to purchase 8 million shares of BioTime common
stock at a pre-specified price. BioTime would own
approximately 71.6%, and a private investor would own approximately
7.0% of the outstanding BAC common stock for their $5
million investment. BioTime would also receive
warrants that would enable it to increase its ownership in BAC by
approximately 2%, which would reduce the Geron stockholders’
ownership in BAC to 19.2%. BAC would also be committed to pay
to Geron royalties on the sale of products that are
commercialized in reliance upon Geron patents acquired by
BAC.”

“The offer couldn’t come at a
better time for Geron, which in recent months has started to feel
pressure from its shareholders to boost its stock price and move
products through the pipeline. Since last November, when the company
announced its decision to shutter its hESC and regenerative medicine
business and funnel its resources into developing telomerase-related
treatments for cancer, the stock price has dropped more than 50
percent to $1.30 a share. Geron claimed the move was simply to save
money, but many took the decision—which effectively terminated a
clinical trial of an hESC treatment for spinal cord injury—as a
setback for the entire field." 

News coverage of yesterday's
announcement was light. Here is a link to a piece by Ryan McBride on
Fierce Biotech.

Source:
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/b-E7JaABIOI/geron-biotime-deal-moves-forward-with.html

Stem Cell Therapy | Stem Cell Malaysia
stemcellmalaysia.com Stem cell therapy is a form of cell therapy that makes use of stem cells harvested from placenta for disease treatment. Stem cell therapy is also used for beauty, anti-aging and health rejuvenation purposes. The efficacy of stem cell therapy has been in practice for decades. Many rich and wealthy individuals and celebrities pay hefty price for stem cell therapy just to maintain youthfulness and vitality. For many severely ill-stricken people who have exhausted all means of conventional therapy look toward stem cell therapy for saving their condition and life. stemcellmalaysia.comFrom:stemcells2012Views:224 2ratingsTime:07:23More inHowto Style

Read the rest here:
Stem Cell Therapy | Stem Cell Malaysia - Video

Mrs. Linda Flournoy
describes ger experience with Stem Cell Therapy PRPFrom:FLRegenerativeMedViews:2 0ratingsTime:02:27More inEducation

Follow this link:
Mrs. Linda Flournoy - Video

MS Journey - Adult Stem Cells Progress.wmv
Breif interview of my progress with Multiple Sclerosis with Adult Stem Cell therapy after my experience with Tysabri, Gilenya and Ampira..From:MSajourneyfromwithinViews:0 0ratingsTime:04:21More inEducation

Link:
MS Journey - Adult Stem Cells Progress.wmv - Video

For Dr. Robert Janson-Mller, the science of fresh cell therapy is in his blood.

His grandfather, Dr. Philipp Janson was one of the few doctors who introduced the treatment in Germany. His father, Dr. Wolfgang Janson-Mller continued the work that was eventually passed on to him.

He was exposed to the revolutionary world of fresh cell therapy early on in life. The treatment uses live young cells from a donor animal like sheep to help regenerate damaged cells in the body. Dr. Mller practically grew up in his grandfather and father's clinic where he met the former's patients, some of whom still go to him for their regular treatments.

''A child always wants to grow up like his father and do the same thing. My father left it open for me. He told me I could do whatever I want, the same thing I am doing now for my daughter. I'm also head of a clinic in Munich. This is what I do besides cell treatment. We have a family practice. That is my main job,'' shares the 46-year-old German doctor who recently visited the Philippines to acquaint Filipinos with the science of fresh cell therapy.

Dr. Mller, who owns a fresh cell therapy laboratory and works as head doctor of Med Activ clinic in Munich, says that despite the growing market for it in America and Asia, there are only five doctors in Germany practicing the science. The treatment is known to deter degenerative diseases such as arthrosis, rheumatism and neurological disorders such as multiple sclerosis. But it is most popular as an anti-aging treatment. Recently, it has also been used to treat children with autism and Down syndrome.

Yet, Dr. Mller points out that fresh cell therapy is not a miracle cure for aging or these diseases. Some bodies accept the treatment while some don't. And, it doesn't treat every disease known to mankind.

Nevertheless, patients from all over the world still flock to his private clinic at the Prinzregent Hotel in Edenkoben, Germany to avail themselves of the treatment, which does not come cheap. One session would cost about $12,000 or R624,000.

''I don't treat patients with cancer, tuberculosis, AIDS, or those who are pregnant. We don't treat patients with acute inflammations like appendicitis. Aside from that, I need to see if it makes sense. If I don't see a possibility, I say no,'' he explains.

In this 60 Minutes interview, Dr. Mller shares how fresh cell therapy really works and how it can take more than just one, two, 20, 60 or even 100 treatments to get it right. Some may start as young as eight months old or continue the treatment at 99 years old. This just proves that a patient is never too young nor too old for this revolutionary treatment. (Angelo G. Garcia)

STUDENTS AND CAMPUSES BULLETIN (SCB): A lot of people are confused about the difference between stem cell and fresh cell therapy.

Read the original:
The cell therapist

Childhood Sarcoma - Oncologist David Loeb
Pediatric oncologist David Loeb, MD, at the Johns Hopkins Kimmel Cancer Center discusses his research in childhood bone cancers or sarcomas. His research includes identifying stem cells within certain types of childhood bone tumors.From:Jay CoreyViews:0 0ratingsTime:04:38More inPeople Blogs

More here:
Childhood Sarcoma - Oncologist David Loeb - Video

Inventing The Future: Stem Cell Research
Click here for more info LiveLab.is What does the future have in store for stem cells? How will this new research and technology affect our everyday lives? Inventing the Future is a live news program featuring coming trends that will shape society. In today #39;s world, success means knowing "What #39;s Next After What #39;s Next?" Lead by Robert Tercek, Inventing the Future offers insight into the future of the world after tomorrow. Inventing the Future, coming 2013 Click here to subscribe httpFrom:LiveLabNetworkViews:36 3ratingsTime:00:37More inScience Technology

Visit link:
Inventing The Future: Stem Cell Research - Video

Stem Cells - A Scene from the Bollywood Film Hope
Watch out a Scene from the Latest Bollywood Film.From:kickassvideosViews:7 0ratingsTime:02:53More inFilm Animation

Here is the original post:
Stem Cells - A Scene from the Bollywood Film Hope - Video

100 Plus - Sonia Arrison
ll4.me 100 Plus - Sonia Arrison Humanity is on the cusp of an exciting longevity revolution. The first person to live to 150 years has probably already been born.What will your life look like when you live to be over 100? Will you be healthy? Will your marriage need a sunset clause? How long will you have to work? Will you finish one career at sixty-five only to go back to school to learn a new one? And then, will you be happily working for another sixty years? Maybe youll be a parent to a newborn and a grandparent at the same time. Will the world become overpopulated? And how will living longer affect your finances, your family life, and your views on religion and the afterlife?In 100 Plus, futurist Sonia Arrison takes us on an eye-opening journey to the future at our doorsteps, where science and technology are beginning to radically change life as we know it. She introduces us to the people transforming our lives: the brilliant scientists and genius inventors and the billionaires who fund their work. The astonishing advances to extend our livesand good healthare almost here. In the very near future fresh organs for transplants will be grown in laboratories, cloned stem cells will bring previously unstoppable diseases to their knees, and living past 100 will be the rule, not the exception.Sonia Arrison brings over a decade of experience researching and writing about cutting-edge advances in science and technology to 100 Plus, painting a vivid picture of a future that ...From:lamardavis9854Views:0 0ratingsTime:00:10More inPeople Blogs

More:
100 Plus - Sonia Arrison - Video

Haute Culture: Tailoring Stem Cells to Make Us Well
Harnessing the body #39;s ability to repair itself, regenerative biology is advancing medicine each day. Our bodies contain stem cells that have the remarkable ability to transform into many different kinds of cells and act as tiny "handymen" to repair damaged tissues. At this April 24, 2012, seminar, faculty members share their expertise and explain how this field of study may dramatically shape the future of medicine. Learn more about the Longwood Seminars by visiting hms.harvard.eduFrom:harvardmedicalschoolViews:1 2ratingsTime:01:30:02More inScience Technology

Read the rest here:
Haute Culture: Tailoring Stem Cells to Make Us Well - Video

In the Bible, Why Doesn #39;t God Address Current Issues?
http://www.str.org -- If God is all-knowing (past why doesn #39;t the Bible cover issues that are relevant today like stem cells, women in authority, artificial insemination, and slavery? If God exists, he would have addressed all these relevant issues in His eternal Bible. Brett Alan tag-team this week #39;s challenge.From:Brett KunkleViews:0 3ratingsTime:04:10More inPeople Blogs

View post:
In the Bible, Why Doesn't God Address Current Issues? - Video

[12 Bottles Herbal Supplements
Buy from Amazon US redirect.viglink.com?key=f341fd9454fc162be8b38d504acbd4e1 out=http%3A%2F%2Fwww%2Eamazon%2Ecom%2Fexec%2Fobidos%2FASIN%2FB007ILYBE0%2Fhealth%5Fhope%2D20 Product Description [12 Bottles This is for 12 bottles of Royal Jelly 1000mg 360s. [[Function It has been reported as a possible immunomodulatory agent. It has also been reported to stimulate the growth of glial cells and neural stem cells in the brain, which may relate to claims for its use as a longer-term cognitive enhancer and as a beneficial agent in cases of Parkinson #39;s Disease.]] --- [[Ingredients: Pure Natural Royal Jelly 1000mg]] --- [[Other Ingredients: gelatin, soy lecithin, glycerin and yellow beeswax]] --- [[Directions: For adults, take one (1) softgel one to three times daily, preferably with a meal. If you have never taken bee products, start with a small serving per day and increase gradually in order to assess whether you are allergic.]] --- [[Store Retail Price: 131.98 per bottle]] Disclaimer: Hope is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon. Amazon and the Amazon logo are trademarks of Amazon, Inc. or its affiliates.From:beatriz phamViews:0 0ratingsTime:00:56More inEducation

Read more from the original source:
[12 Bottles Herbal Supplements - Video

[5 Royal
Buy from Amazon US redirect.viglink.com?key=f341fd9454fc162be8b38d504acbd4e1 out=http%3A%2F%2Fwww%2Eamazon%2Ecom%2Fexec%2Fobidos%2FASIN%2FB007ILIRJA%2Fhealth%5Fhope%2D20 Product Description [5 Royal This is for 5 bottles of Royal Jelly 1000mg 360s. [[Function It has been reported as a possible immunomodulatory agent. It has also been reported to stimulate the growth of glial cells and neural stem cells in the brain, which may relate to claims for its use as a longer-term cognitive enhancer and as a beneficial agent in cases of Parkinson #39;s Disease.]] --- [[Ingredients: Pure Natural Royal Jelly 1000mg]] --- [[Other Ingredients: gelatin, soy lecithin, glycerin and yellow beeswax]] --- [[Directions: For adults, take one (1) softgel one to three times daily, preferably with a meal. If you have never taken bee products, start with a small serving per day and increase gradually in order to assess whether you are allergic.]] --- [[Store Retail Price: 131.98 per bottle]] Disclaimer: Hope is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon. Amazon and the Amazon logo are trademarks of Amazon, Inc. or its affiliates.From:virgen crispViews:0 0ratingsTime:00:56More inScience Technology

Read more here:
[5 Royal - Video